UC AKT.ANL. 12/24 SAX/ DE000HD1QQ54 /
09/05/2024 11:47:21 | Chg.-0.150 | Bid13:02:29 | Demandez à13:02:29 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
102.090EUR | -0.15% | 101.980 Bid taille: 125,000 |
102.130 Ask la taille: 125,000 |
STROEER SE + CO. KGA... | 44.00 - | 31/12/2024 | Call |
Newsfile Corp
13:30
Cosa Resources Announces Summer Exploration Plans for Athabasca Basin Uranium Projects
GlobeNewswire
13:30
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
13:30
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
GlobeNewswire
13:30
Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:30
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:30
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
GlobeNewswire
13:30
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
GlobeNewswire
13:30
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
13:30
Destination XL Group, Inc. to Announce First Quarter 2024 Financial Results on May 30, 2024
GlobeNewswire
13:30
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
13:30
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
GlobeNewswire
13:30
Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2024
GlobeNewswire
13:30
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Updat...
GlobeNewswire
13:30
Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Upda...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page